Company Profiles

driven by the PitchBook Platform

Carmell Therapeutics

Description

Developer of medical devices manufactured from blood plasma. The company's proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue.

2007

Founded

PRIVATE

Status

1-10

Employees

Angel

Latest Deal Type

$1.5M

Latest Deal Amount

$7.28M

Total Amount Raised

Description

Developer of medical devices manufactured from blood plasma. The company's proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue.

Website:

www.carmellrx.com

Formerly Known As

CarMell

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Other Devices and Supplies

Primary Office

3636 Boulevard of the Allies Pittsburgh, PA 15213United States +1 (412) 508-6519
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Carmell Therapeutics's full profile, request a free trial.

    Carmell Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Carmell Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Carmell Therapeutics Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Ariel Southeast Angel PartnersAngel GroupMinority000 0000000 0000
    BlueTree Allied AngelsVenture CapitalMinority000 0000000 0000
    Harbor Light Capital PartnersVenture CapitalMinority000 0000000 0000
    Innovation WorksVenture CapitalMinority000 0000000 0000
    Keiretsu ForumVenture CapitalMinority000 0000000 0000
    Ariel Southeast Angel Partners Angel Group
    BlueTree Allied Angels Venture Capital
    Harbor Light Capital Partners Venture Capital
    Innovation Works Venture Capital
    Keiretsu Forum Venture Capital

    Carmell Therapeutics Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Randy HubbellCo-Chief Executive Officer, President and Chairman
    Alan WestCo-Chief Executive Officer
    Phil Campbell Ph.DCo-Founder & Chief Scientific Officer
    Donna GodwardChief Quality Officer
    James Burgess MDCo-Founder
    Randy Hubbell Co-Chief Executive Officer, President and Chairman
    Alan West Co-Chief Executive Officer
    Phil Campbell Ph.D Co-Founder & Chief Scientific Officer
    Donna Godward Chief Quality Officer
    James Burgess MD Co-Founder

    Carmell Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    David AndersonCarmell TherapeuticsBoard Member000 0000
    James JordanPittsburgh Life Sciences GreenhouseChief Executive Officer, Vice President & Board Member000 0000
    Lee Weiss Ph.DCarmell TherapeuticsCo-Founder & Director000 0000
    Richard UptonHarbor Light Capital PartnersGeneral Partner000 0000
    William Newlin Ph.DNewlin Investment CompanyChairman000 0000
    David Anderson Board Member Carmell Therapeutics
    James Jordan Chief Executive Officer, Vice President & Board Member Pittsburgh Life Sciences Greenhouse
    Lee Weiss Ph.D Co-Founder & Director Carmell Therapeutics
    Richard Upton General Partner Harbor Light Capital Partners
    William Newlin Ph.D Chairman Newlin Investment Company
    Request full access to PitchBook